ArticleBlood advances2021

Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.

Chang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.